(Q34020812)

English

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Impact of pharmaceutical policy interventions on utilization of antipsychotic medicines in Finland and Portugal in times of economic recession: interrupted time series analyses (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

0 references

Christine Leopold

object named as

Christine Leopold

1

0 references

Dennis Ross-Degnan

6

object named as

Dennis Ross-Degnan

1 reference

Europe PubMed Central

30 July 2017

Anita K. Wagner

7

object named as

Anita K Wagner

1 reference

Europe PubMed Central

30 July 2017

author name string

Fang Zhang

2

1 reference

Europe PubMed Central

30 July 2017

Aukje K Mantel-Teeuwisse

3

1 reference

Europe PubMed Central

30 July 2017

Sabine Vogler

4

1 reference

Europe PubMed Central

30 July 2017

Silvia Valkova

5

1 reference

Europe PubMed Central

30 July 2017

publication date

25 July 2014

1 reference

Europe PubMed Central

30 July 2017

International Journal for Equity in Health

1 reference

Europe PubMed Central

30 July 2017

13

1 reference

Europe PubMed Central

30 July 2017

53

1 reference

Europe PubMed Central

30 July 2017

https://scigraph.springernature.com/pub.10.1186/1475-9276-13-53

0 references

Pharmaceutical policies in European countries in response to the global financial crisis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Changes in equity in out-of-pocket payments during the period of health care reforms: evidence from Hungary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Reimbursement restriction and moderate decrease in benzodiazepine use in general practice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

The 2007-09 recession and health insurance coverage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Pharmaceutical policies: effects of restrictions on reimbursement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Unintended impacts of a Medicaid prior authorization policy on access to medications for bipolar illness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Methods for estimating confidence intervals in interrupted time series analyses of health interventions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Effect of a medication copayment increase in veterans with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Patient access to pharmaceuticals: an international comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Reference pricing of pharmaceuticals for Medicare: evidence from Germany, The Netherlands, and New Zealand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

A critical analysis of studies of state drug reimbursement policies: research in need of discipline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

28 July 2018

The exclusion of benzodiazepine coverage in medicare: simple steps for avoiding a public health crisis

1 reference

https://api.crossref.org/works/10.1186%2F1475-9276-13-53

21 January 2018

Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates.

1 reference

https://api.crossref.org/works/10.1186%2F1475-9276-13-53

21 January 2018

Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy.

1 reference

https://api.crossref.org/works/10.1186%2F1475-9276-13-53

21 January 2018

Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002.

1 reference

https://api.crossref.org/works/10.1186%2F1475-9276-13-53

21 January 2018

Psychiatrists' attitude towards and knowledge of clozapine treatment

1 reference

https://api.crossref.org/works/10.1186%2F1475-9276-13-53

21 January 2018

The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand.

1 reference

https://api.crossref.org/works/10.1186%2F1475-9276-13-53

21 January 2018

Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1186%2F1475-9276-13-53

21 January 2018

Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

29 October 2018

Clinical effects of a randomized switch of patients from clozaril to generic clozapine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4126811

29 October 2018

Segmented regression analysis of interrupted time series studies in medication use research

1 reference

https://pubmed.ncbi.nlm.nih.gov/25062657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care

1 reference

https://pubmed.ncbi.nlm.nih.gov/25062657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of generic substitution on price competition in Finland

1 reference

https://pubmed.ncbi.nlm.nih.gov/25062657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1475-9276-13-53

1 reference

Europe PubMed Central

30 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34020812&oldid=2075075986"